The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis

Frontiers Diagnosis for Latent Tuberculosis Infection: New Alternatives

Diagnostics, Free Full-Text

Framework for the evaluation of new tests for tuberculosis infection

Evaluation of ESAT6-CFP10 Skin Test for Mycobacterium tuberculosis Infection among Persons Living with HIV in China

IFN-γ and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

ATBdiscrimination: An in Silico Tool for Identification of Active Tuberculosis Disease Based on Routine Blood Test and T-SPOT.TB Detection Results

Frontiers Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy

FIGURE 1 – Evolution of diagnostic methods for latent TB

Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays

Flow diagram of dose-finding trial. TB patients received C-Tb

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

Qualitative evidence for the use of Mycobacterium tuberculosis antigen-based skin tests - WHO consolidated guidelines on tuberculosis - NCBI Bookshelf